Skip to main content
. 2007 Apr;3(2):203–210. doi: 10.2147/vhrm.2007.3.2.203

Figure 6.

Figure 6

Percentage of patients reaching the HbA1c goal of <7% in mono or combination therapy studies with sitagliptin. Studies of 24 weeks’ duration are shown: sitagliptin monotherapy (left panel) (from data of Aschner et al 2006b), combination with metformin (middle panel) (from data of Karasik et al 2006), combination with pioglitazone (right panel) (from data of Rosenstock et al 2006a).